Breaking News, Promotions & Moves

Cambrex Names Tom Vadaketh EVP and CFO

Greg Sargen to take up new post as EVP, corporate development and strategy

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cambrex Corporation has named Tom Vadaketh executive vice president and chief financial officer, effective January 20, 2017. Greg Sargen, current chief financial officer at Cambrex, will transition to a newly created role, executive vice president, corporate development and strategy. In his new role, Mr. Sargen will assume responsibility for corporate development and strategy and will continue to report directly to Steven Klosk, president and chief executive officer. “We are excited to welcom...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters